Brain Health

This test measures antibodies against acetylcholine receptors in the blood, which are associated with autoimmune disorders like myasthenia gravis. The presence of these antibodies can disrupt nerve-to-muscle communication, causing muscle weakness, fatigue, and difficulty controlling facial or limb muscles. Blood analysis helps confirm diagnosis, guide treatment planning, and monitor disease progression. Patients benefit by understanding the cause of their symptoms, enabling timely therapy and management strategies to improve muscle strength and daily functioning. Early detection allows healthcare providers to implement treatments that reduce symptom severity and prevent complications, supporting long-term health and quality of life.

This test detects autoantibodies affecting myelin in the central nervous system, associated with demyelinating disorders such as optic neuritis or transverse myelitis. Blood is drawn, and results are analysed to guide diagnosis, monitoring, and treatment planning. Early detection helps prevent neurological damage, supports timely therapy, and improves patient outcomes by addressing inflammation and protecting nerve function. Understanding antibody status aids healthcare providers in tailoring interventions for long-term neurological health.

This test detects aquaporin 4 antibodies, which are associated with neuromyelitis optica, a rare autoimmune disorder affecting the optic nerves and spinal cord. Blood is collected and analysed to diagnose and monitor the condition. Early detection allows healthcare providers to implement immunosuppressive therapy, prevent relapses, and manage symptoms. Understanding antibody status helps patients reduce neurological damage, maintain mobility, and improve quality of life through tailored treatment and monitoring.